Telsey Advisory downgraded Waldencast (WALD) to Market Perform from Outperform with an unchanged price target of $3.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WALD:
- Waldencast Reports Mixed Q2 and Q3 2025 Results
- Midday Fly By: Novo Alzheimer’s trial misses goal, Green Dot to be acquired
- Waldencast Expands U.S. Market Presence with Novaestiq Acquisition
- Waldencast Reports Q2 2025 Results and Strategic Updates
- Morning Movers: Novo Nordisk sinks after Alzheimer’s disease study results